Main content

Our partners

Ipsen Pharma
In September, 2011 Photocure entered into a strategic collaboration with Ipsen, a global specialty-driven biopharmaceutical company focused on four franchises, including uro-oncology, to commercialize Hexvix® worldwide, excluding the US and Nordic regions. Ipsen has a strong and well established uro-oncology franchise and will commercialize Hexvix through its dedicated urology sales force. Ipsen has its headquarter in Paris, France, and commercial presence in 49 countries. Photocure retained the rights to the product in the Nordics and the US.
Ipsen web page

Right column